Dupuytren's Disease Treatment | Raleigh Hand Surgeon – Dr. Stephen Chambers
No Referral Needed · Same-Day Appointments · Raleigh, Cary, Holly Springs & Wake Forest ☎ (919) 781-5600
Hand Conditions

Dupuytren's Disease
Treatment in Raleigh, NC

Fingers curling toward your palm? Trouble gripping, shaking hands, or flattening your palm on a table? Dr. Stephen Chambers offers expert, minimally invasive treatment — often without surgery.

Common Symptoms
Thick nodule or cord in the palm
Finger(s) bending toward palm
Cannot lay hand flat on a table
Difficulty with gloves, pockets, or gripping
Usually painless — but may ache
Ring or little finger most affected
8%
Worldwide disease prevalence
More common in men than women
80%
Of disease risk is genetic
98%
Immediate MCP correction with needle aponeurotomy
Understanding Your Condition

What Is Dupuytren's Disease?

Dupuytren's disease (doo-pwe-TRANZ) is a condition where the connective tissue beneath the skin of the palm gradually thickens into nodules and cords. Over time, these cords tighten and pull one or more fingers—most often the ring and little fingers—into a bent position.

The condition is not cancerous and is usually not painful. Many patients live with it for years before it interferes with daily activities. However, once the contracture limits hand function, treatment can dramatically restore your range of motion.

ⓘ Dupuytren's disease is not caused by heavy lifting, injury, or overuse — it is primarily a genetic condition. Having a family member with it significantly raises your risk.

Who Is at Risk?

Risk Factors

Several factors are associated with a higher likelihood of developing Dupuytren's disease:

🧬

Family History

Strongest risk factor — inherited condition

👤

Male Sex

Men are 3× more likely to develop it

🌍

N. European Ancestry

Scandinavian, Celtic, British descent

🎂

Age 50+

Risk increases with age

🩸

Diabetes

Modestly increases prevalence

🚬

Smoking

Associated with higher risk

Disease Progression

Stages of Dupuytren's Disease

Dupuytren's progresses at different rates in different people — some patients stay at an early stage for decades, while others progress quickly. Understanding your stage helps guide treatment timing.

Early Stage

A small nodule or pit forms in the palm. Finger movement is usually normal. Often mistaken for a callus.

Firm nodule in the palm
No significant finger contracture
May be tender to touch
Monitoring recommended
Moderate Stage

A cord has formed and begins to pull the finger. You may notice difficulty fully opening your hand.

Visible cord under skin
Finger 30–60° bent (contracture)
Difficulty gripping or gloving
Treatment often recommended
Advanced Stage

The finger is significantly contracted, interfering with daily activities like handshakes or washing your face.

Contracture >60°
Cannot lay hand flat
Significant functional loss
Prompt treatment advised
How We Diagnose

Diagnosis

Dupuytren's disease is typically diagnosed through a clinical examination — no imaging or blood tests are usually required. Dr. Chambers will examine your hand and fingers to assess the degree of contracture and determine the best treatment approach.

  • Visual inspection of nodules and cords
  • Measurement of finger contracture angles
  • Assessment of which joints are involved (MCP and/or PIP)
  • Grip strength and range-of-motion testing
  • Review of family history and medical conditions
  • X-rays if arthritis or other conditions are suspected
Self-Check at Home

The Tabletop Test

A simple way to check if Dupuytren's may be affecting your hand function:

▶ How to perform it

Place your hand palm-down on a flat table. If you cannot press your hand flat against the surface — if any fingers lift off — this is a positive tabletop test. This suggests meaningful contracture and is a common trigger for seeking evaluation.

📅 When to See Dr. Chambers

You don't need a referral. If you notice a nodule in your palm, a cord, or a finger beginning to curl — even mildly — come in for an evaluation. Early intervention often means simpler, less invasive treatment options.

Evidence-Based Results

Treatment Outcomes & Complication Rates

Understanding what the research shows helps you make an informed decision. Below are published outcome and complication data for each treatment option. Dr. Chambers will review what these numbers mean for your specific situation at your appointment.

98%
MCP Joint Correction

Immediate correction to ≤5° at the knuckle joint after needle aponeurotomy

67%
PIP Joint Correction

Immediate correction at the middle finger joint (harder to treat)

50–58%
5-Year Recurrence

Recurrence rate at 3–5 year follow-up — can be re-treated

Days
Recovery Time

Most patients return to normal activities within days, not weeks

Complication Profile

ComplicationRateSeverityNotes
Skin tear / split9–25%MinorSuperficial; heals without intervention in most cases
Nerve injury (neuropraxia)<1%ModerateTemporary numbness; permanent injury extremely rare
Swelling / bruisingCommonMinorExpected; resolves within 1–2 weeks
Infection<1%ModerateVery rare with sterile technique
Overall serious complication<2%LowLowest complication profile of all three options

Sources: Watt et al., J Hand Surg 2021; Ball et al., J Hand Surg 2012

80%+
Immediate Full Correction

Over 80% achieve full deformity correction immediately after procedure

70%
Initial Success Rate

70% of injections meet clinical success criteria (reduction to ≤5°)

25%
5-Year Recurrence

Lower recurrence than needle aponeurotomy; re-treatment is effective

92%
Patient Satisfaction

Very satisfied or satisfied at 5-year follow-up in collagenase studies

MCP Joint Outcomes at 3 Years (Collagenase)

Full correction (0–5°)
73%
Partial improvement
14%
Recurrence (≥20° worsening)
14%

Complication Profile

ComplicationRateSeverityNotes
Bruising / hematoma~23%MinorMost common side effect; self-resolving
Swelling / edema~19%MinorTypical inflammatory response; resolves in 1–2 weeks
Skin tear at manipulation9–25%MinorSmall tears at manipulation; heals without stitches
Allergic / anaphylactic reaction<0.1%Rare/SeriousOffice monitoring for 30 min post-injection
Tendon rupture<0.3%Rare/SeriousRisk reduced by careful injection technique

Sources: Kauffman et al., Hand 2023; Mehta et al., Cureus 2021; Alamer et al., Heliyon 2024

90%
Excellent/Good Results

~67% excellent + 23% good outcomes at 4-year follow-up after fasciectomy

12–39%
5–7 Year Recurrence

Lower long-term recurrence than non-surgical options for most patients

14–67%
Minor Complication Rate

Includes wound healing, sensitivity, stiffness — most resolve fully

6–12 wks
Recovery

Return to most activities in 6–12 weeks; heavy labor may take longer

Surgical Outcomes Breakdown

Excellent (full movement)
67%
Good (minor limitations)
23%
Fair (some recurrence)
9%

Complication Profile

ComplicationRateSeverityNotes
Wound healing issues / scarring~23%MinorMost common; managed with hand therapy and scar care
Numbness / cold sensitivityCommonMinorOften temporary; seen in areas where skin was elevated
StiffnessVariesModerateAddressed with hand therapy post-operatively
Infection4–12%ModerateTreated with antibiotics; rarely requires further surgery
Digital nerve injury~3.4%Serious~10× higher in recurrent disease vs. primary surgery
Complex regional pain syndrome~5.5%SeriousCRPS requires specialized pain management
Digital artery injury~2%SeriousRare with experienced surgeon; higher in recurrent disease

Important context: Major complication rates (nerve injury, artery injury) are approximately 10× higher for recurrent Dupuytren's than for first-time surgery. This is one reason early treatment, before multiple recurrences, often yields better results.

Sources: Denkler, Plast Reconstr Surg 2010; Eray et al., 2017

Quick Comparison at a Glance

Metric Needle Aponeurotomy Collagenase (Xiaflex®) Fasciectomy
Immediate correction (MCP)98%80%+~95%
5-year recurrence50–58%25%12–39%
Recovery timeDaysDays–1 week6–12 weeks
Incision requiredNoNoYes
AnesthesiaLocalLocalLocal (WALANT) or regional
Best forSingle cord, older patients, fast recovery prioritySingle cord, MCP contractureSevere/advanced, multiple cords, recurrent disease
Your Options

Treatment Options

Dr. Chambers offers all three evidence-based treatments for Dupuytren's disease and will help you choose the approach best suited to your stage, goals, and lifestyle. Many patients are candidates for non-surgical procedures with minimal downtime.

Non-Surgical

Needle Aponeurotomy (NA)

A needle is used to puncture and break the cord under the skin. No incision is required. This office procedure can often be performed under local anesthesia in a single visit, with immediate improvement in finger extension.

No incision or stitches
Same-day, in-office procedure
Recovery time of days, not weeks
Can be repeated if recurrence
Non-Surgical

Collagenase Injection (Xiaflex®)

An enzyme (collagenase) is injected directly into the cord, breaking down the collagen that forms it. The following day, the finger is extended in a controlled manipulation to straighten it. FDA-approved for Dupuytren's contracture.

No surgery or cuts
Two-visit protocol
Clinically proven effectiveness
Good for isolated cord contractures
Surgical

Fasciectomy (Surgery)

The affected cord and thickened tissue are surgically removed. This option is typically reserved for more advanced contractures, multiple cords, or recurrent disease. Dr. Chambers performs this under wide-awake (WALANT) technique when appropriate.

Most complete tissue removal
Best option for complex disease
WALANT option — no general anesthesia
Excellent long-term outcomes
After Treatment

What to Expect During Recovery

Recovery depends on the type of treatment. Here is a general guide for surgical fasciectomy — non-surgical procedures typically have a much faster recovery.

Day 1–3

Initial Recovery

Hand is bandaged. Keep hand elevated to reduce swelling. Pain is typically well-controlled with oral medication. Ice can help.

Week 1–2

Wound Healing & Splinting

Sutures are removed around 10–14 days. A night splint keeps the finger extended while you sleep. Light activities with the hand are usually possible.

Week 2–6

Hand Therapy

Formal hand therapy begins to restore range of motion and strength. Most patients see significant improvement in finger extension within this window.

Month 2–3

Return to Full Activity

Most patients return to all daily activities and work. Heavy manual labor and grip-intensive sports may require additional time.

Long-Term

Monitoring for Recurrence

Dupuytren's can recur, especially in patients with strong genetic predisposition. Annual check-ins help catch any recurrence early when it's easiest to treat.

📋 Post-operative instructions, scar care, and therapy referrals are provided at your visit. See also: Post-Op Instructions and Scar Treatment.

Common Questions

Frequently Asked Questions

Dupuytren's disease is usually not painful. Some patients feel mild tenderness at the nodule in the early stages, but the contracture itself typically does not cause significant pain. If you are experiencing pain, it's important to have the hand evaluated to rule out other conditions.

No referral is needed. Dr. Chambers accepts patients directly, and same-day appointments are often available at his Raleigh, Cary, Holly Springs, and Wake Forest locations. Simply call (919) 781-5600 or book online.

Unfortunately, Dupuytren's disease does not resolve on its own. It is a progressive condition, meaning it typically worsens over time — though the rate of progression varies greatly between individuals. Mild cases can sometimes remain stable for years. Treatment is recommended once the contracture begins to interfere with daily activities or the tabletop test is positive.

Needle aponeurotomy (NA) is a minimally invasive office procedure using a needle to break the cord — no incision, no stitches, and recovery is measured in days. Fasciectomy (surgery) involves removing the diseased tissue through an incision and is better suited for advanced contractures or multiple cords. Surgery has a lower recurrence rate but involves a longer recovery. Dr. Chambers will discuss which is best for your situation.

Yes, recurrence is possible, particularly in patients with a strong genetic predisposition ("Dupuytren's diathesis"). Needle aponeurotomy has a higher recurrence rate than surgical fasciectomy. However, if disease does recur, it can often be treated again. Regular follow-up allows Dr. Chambers to catch early recurrence when it is most amenable to simple treatment.

Most major insurance plans cover treatment for Dupuytren's contracture when it is functionally significant. Coverage details depend on your specific plan. Our team at Raleigh Orthopaedic can assist you with insurance verification. See our insurance information page for more details.

Ready to Straighten Things Out?

No referral needed. Dr. Chambers offers same-day appointments at four convenient locations across the Triangle. Call or book online today.

Dr. Stephen Chambers, Hand Surgeon

Stephen Chambers, M.D.

Board-Certified Hand & Upper Extremity Surgeon · Raleigh Orthopaedic

Fellowship-Trained ASSH Member Pitt Hand & UE Fellowship Campbell Clinic Residency

Learn more about Dr. Chambers →